Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

6-Chloropurine Riboside

    • Product Name 6-Chloropurine Riboside
    • Alias Nebularine
    • Einecs 207-377-1
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    662067

    Product Name 6-Chloropurine Riboside
    Synonyms 6-Chloropurine-9-β-D-ribofuranoside
    Cas Number 146-80-5
    Molecular Formula C10H10ClN5O4
    Molecular Weight 299.67 g/mol
    Appearance White to off-white crystalline powder
    Purity Typically ≥98%
    Solubility Soluble in water and DMSO
    Melting Point 221-225°C
    Storage Temperature 2-8°C (Refrigerated)
    Iupac Name 1-[(2R,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-chloropurine
    Ec Number 205-701-1

    As an accredited 6-Chloropurine Riboside factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 6-Chloropurine Riboside, 1g, supplied in a clear, tightly sealed glass vial with a white screw cap and labeled details.
    Shipping 6-Chloropurine Riboside is typically shipped in tightly sealed containers, protected from light and moisture. It is packed in accordance with regulations for chemical transport, ensuring safe handling and compliance with hazardous materials guidelines. Temperature control may be applied to maintain stability during transit. Safety documentation accompanies all shipments.
    Storage 6-Chloropurine Riboside should be stored in a cool, dry, and well-ventilated area, away from moisture and direct sunlight. Keep the container tightly closed when not in use. Store at 2-8°C (refrigerated) for optimal stability. Handle under inert atmosphere if possible, and avoid exposure to strong acids, bases, or oxidizing agents. Follow standard laboratory safety protocols.
    Application of 6-Chloropurine Riboside

    Applications of 6-Chloropurine Riboside in Industrial Manufacturing

    6-Chloropurine Riboside serves as a critical intermediate in specialized chemical processes across pharmaceutical, biotechnology, and nucleoside derivative manufacturing. Below we outline the primary industrial sectors where this compound is integrated, with details on compliance frameworks, technical usage, downstream processes, and product outcomes.

    1. Pharmaceutical Antiviral API Synthesis

    Pharmaceutical manufacturers utilize this compound as a building block for synthesizing purine nucleoside analogues, which are foundational for several classes of antiviral and antineoplastic drug substances. It contributes directly to the nucleoside backbone formation during active pharmaceutical ingredient (API) assembly, especially where targeted halogenation is required for controlled activity and metabolic stability.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • USP-NF (United States Pharmacopeia–National Formulary)
    • European Pharmacopoeia (Ph. Eur.) requirements for intermediates
    • 21 CFR Part 211 (FDA cGMP regulations for finished pharmaceuticals)

    Typical usage ratio

    • Serves as a key intermediate, typically added at 1–5% molar equivalent relative to other nucleoside substrates, depending on target compound yield and successive reaction steps. Adjustment based on substrate conversion efficiency and residue control in downstream purification.

    Downstream process integration

    • Introduced during the nucleoside synthesis phase via either direct chlorination or glycosylation route, with subsequent derivatization, deprotection, and purification unit operations to yield high-purity, drug-grade nucleoside APIs.

    Final product types

    • Active pharmaceutical ingredients for antiviral medications (e.g., anti-Herpesviridae agents)
    • Chemotherapeutic drug substances incorporating halogenated nucleosides
    • Advanced pharmaceutical intermediates for further downstream transformations

    2. Nucleoside-Based Diagnostic Reagent Manufacturing

    Diagnostic reagent producers integrate this compound during the preparation of nucleoside substrates for biochemical assays, including enzymatic and molecular biology test kits. Its structural features allow site-specific labeling or further modification, supporting production of actives for in vitro detection technologies.

    Industry compliance standards

    • ISO 13485 Medical Devices – Quality Management for diagnostic reagents
    • FDA 21 CFR 820 for In Vitro Diagnostic Device Quality System Regulation
    • CLSI (Clinical and Laboratory Standards Institute) guidelines for diagnostic reagents
    • EU IVDR (In Vitro Diagnostic Medical Devices Regulation)

    Typical usage ratio

    • Incorporated in precursor solution at 0.5–2% w/w depending on final nucleoside modification, substrate conversion rate, and downstream reagent stability.

    Downstream process integration

    • Added during the nucleoside modification or enzymatic coupling stage, followed by chemical or enzymatic derivatization, and incorporated as a functionalized nucleoside in buffered assay formulations.

    Final product types

    • Labeled or modified nucleoside reagents for PCR/qPCR kits
    • Nucleotide analogues for in vitro biochemical assays
    • Probes and standards for clinical diagnostics and molecular research

    3. Custom Oligonucleotide Synthesis

    Oligonucleotide manufacturers select this compound as a starting material for synthetic protocols that introduce chloropurine bases into DNA or RNA sequences. By providing this nucleoside with controllable reactivity, custom oligonucleotide shops can offer unique modified sequences for pharmaceutical R&D and genetic research purposes, meeting detailed customization requests.

    Industry compliance standards

    • GMP guidelines for oligonucleotide APIs (as per ICH Q11)
    • ISO 9001:2015 Quality Management Systems
    • USP Chapter <1045> for Biotechnology-Derived Products
    • Ph. Eur. and JP standards for oligonucleotide intermediates, where applicable

    Typical usage ratio

    • Dosage dependent on desired sequence length and modification pattern; usually 1 molar equivalent per modified site within the oligo chain, with overall batch concentrations ranging from 0.1–1% w/v in synthesis solutions. Final ratio optimized for coupling yield and sequence fidelity.

    Downstream process integration

    • Integrated directly during the solid-phase synthesis cycle, where it acts as a modified phosphoramidite building block or as a precursor for post-synthesis modification steps.

    Final product types

    • Chloropurine-modified oligonucleotides for gene editing research
    • Custom probes for SNP detection and hybridization assays
    • Synthetic RNA/DNA tools for pharmaceutical development and functional genomics

    4. Agricultural Biochemical Research Supplies

    Agrochemical R&D laboratories use this material as a specialized nucleoside intermediate for investigating plant biochemical pathways, particularly in studies of nucleic acid analogues and metabolic inhibitors. Its distinct purine base enables the design of functional probes and experimental plant growth regulators.

    Industry compliance standards

    • GLP (Good Laboratory Practice, OECD Principles) for experimental research chemicals
    • ISO/IEC 17025 for testing and calibration labs
    • National guidelines for agricultural chemical research (e.g., EPA FIFRA for experimental use permits in the US)
    • REACH compliance for laboratory chemicals in the EU

    Typical usage ratio

    • Typical tissue culture and experiment concentrations range from 0.01–0.1 mM, with adaptions based on plant species sensitivity and research protocol. Item incorporated at a working solution ratio, directly into hydroponic or micropropagation media.

    Downstream process integration

    • Prepared as a stock solution and introduced to plant cell, tissue, or seedling cultures for bioassay applications. Also potentially coupled or derivatized before application for pathway elucidation studies.

    Final product types

    • Experimental reagents for plant metabolic pathway mapping
    • Functionalized nucleoside standards for agrochemical analytical kits
    • Reference substances in plant genetics and growth regulator effect assessment
    Free Quote

    Competitive 6-Chloropurine Riboside prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introducing 6-Chloropurine Riboside: The Manufacturer’s Perspective

    6-Chloropurine Riboside: What It Is and Why It Matters

    Years of hands-on chemical manufacturing teach lessons that can’t be found in any catalog. Each compound in our portfolio occupies a space defined by its performance, demand, and scientific potential. 6-Chloropurine riboside, produced to stringent in-house specifications, consistently shows up as a reliable choice for research communities and biotech innovators. Chemists searching for quality nucleoside analogs know that the difference lies in how the product is built from the ground up. Precision, repeatability, and transparency in manufacturing carry through into every shipment that leaves our facility.

    A direct chemical derivative of purine, fitted with a chlorine at the 6-position and coupled to a ribose sugar, 6-chloropurine riboside is a clear example of how careful process control creates a product that helps scientists do more. We don’t just list it; we make it. That means control over each variable, from the underlying purity of incoming reagents to the moisture monitoring on the final batch. Years of refining the synthesis route—paying attention to temperature, pH, and solvent quality—lead to a compound with consistent performance in sensitive applications.

    Specifications That Support Real Results

    Labs rely on consistency, regardless of whether orders call for grams or kilos. We set our standards for 6-chloropurine riboside at a minimum purity of 98 percent, measured by HPLC. The melting point and other physical properties are controlled with the same attention. Storage and packaging keep the material stable in ambient conditions for extended periods, so tight timelines don’t compromise results. Each batch is checked for trace contaminants, with specifications targeting residual solvents well below recognized thresholds. This attention grows from in-house experience testing reactions and troubleshooting failed syntheses.

    From day one, we realized that variability in nucleoside analogs leads to inconsistent results in downstream experiments. Researchers struggled to achieve comparable outcomes. The lessons became clear: don’t cut corners, and document every step. This philosophy informs every lot of 6-chloropurine riboside we prepare. Our model for this product isn’t just about purity; it’s about handing over a tool that does exactly what it should: act as a dependable building block for further chemical transformations.

    Applications: Where Chemists Put 6-Chloropurine Riboside to Work

    This molecule stands out as more than just another nucleoside. Its chlorinated purine core gives it unique reactivity, especially in the hands of medicinal chemists and nucleic acid researchers. In our experience, clients most often use it as a precursor for introducing modified purine bases into nucleic acids and oligonucleotides. The chlorine atom at position six is reactive toward nucleophilic substitution, so the compound readily serves as a scaffold for further derivatization. Synthetically, this opens doors to analogs that help probe biological mechanisms or fine-tune drug candidates.

    6-Chloropurine riboside operates at the intersection of organic synthesis and biochemistry. Academic researchers and pharmaceutical R&D teams use it in structure-activity relationship studies, preparing analogs of adenosine or guanosine that are difficult to access through direct modification. The selectable chlorine offers a handle for replacing it with amine, alkoxy, or other nucleophiles, giving rise to a spectrum of unnatural nucleosides. In our own collaborations with academic labs, feedback keeps coming in about the robust nature of our material—reacting cleanly, minimizing side products, and yielding higher conversions compared to less rigorously prepared alternatives.

    Beyond conventional lab benches, some companies apply 6-chloropurine riboside to personalized medicine projects, functionalizing oligonucleotides for targeted therapies. The controlled impurity profiles prevent unexpected side reactions in large-scale synthesis runs, a crucial point when producing materials for further modification or use in clinical pipelines. Molecular biologists put it to use, too—exploring nucleic acid analogues for enzyme specificity, or mapping out pathway inhibitors in vitro.

    The product’s reliability also comes into focus in molecular diagnostic technologies. Modified nucleosides influence hybridization behaviors, probe design, and signal amplification, all of which hinge on feedstock that performs predictably batch after batch. Our record of ongoing supply meets the needs of both large contract research organizations and smaller academic shops, with documentation to support rigorous audits.

    Differences from Other Nucleoside Analogs

    Manufacturing puts us on the front line of demand shifts. We get requests for a dozen nucleoside derivatives every week, but the structure of 6-chloropurine riboside gives it some clear advantages and distinctions. Unlike unsubstituted purine ribosides, the 6-chloro group creates a gateway for chemical modifications not possible with similar molecules. Adenosine and guanosine, traditional core nucleosides, lack this handle, so their transformation requires more elaborate procedures or harsher reagents. The mild conditions required for substitution on the chlorine make synthesis of new analogs both easier and more scalable.

    Investing in process chemistry for this molecule taught us that reproducibility comes not just from following a recipe, but understanding exactly where unwanted byproducts emerge and taking action upstream. Some non-chlorinated nucleoside syntheses offer more gentle conditions but fail to provide that same platform for diversification. Our 6-chloropurine riboside yields clean subsequent reactions, reducing purification steps after derivatization. Researchers save time and resources without facing bottlenecks caused by mixed products.

    From a practical view, the molecule’s crystalline form and solid-state behavior give it superior handling and storage characteristics in our packing operations compared with other nucleosides that are prone to hygroscopicity or rapid decomposition. Powder flows better, doses accurately, and doesn’t clump during shipping. We keep track of customer feedback, especially when scaling up. Performance during transportation has always favored the robust crystalline properties of our 6-chloropurine riboside batches.

    In terms of cost, our in-house synthesis route for this molecule, fine-tuned over years, lets us control margins and invest back into advanced analytical screening. Other nucleoside analogs—especially those requiring extensive protecting group chemistry—still carry unpredictably higher prices. By focusing on reaction yields and minimizing solvent waste, we’ve been able to keep costs competitive while pushing for greater batch-to-batch consistency.

    Quality Assurance and Traceability—A Manufacturer’s Pledge

    Stability and purity demand more than just analytical confirmation. Over the years, too many products in the open market arrive accompanied by vague certificates and batch inconsistencies. Our philosophy roots in personal accountability. Each drum or bottle of 6-chloropurine riboside carries not just an identification label, but also a batch record that can trace the history of each lot—starting from raw material supplier certification through final quality release by our internal teams.

    These measures go beyond ticking regulatory boxes. Feedback from university research groups and pharmaceutical partners often includes stories of disrupted experiments elsewhere due to improper storage, variable purity, or misleading documentation. Mistakes at our end lead to wasted time and money for our customers, so we set our controls tighter than industry averages. Material is routinely tested not only for composition, but also for solubility, stability under heat, and compatibility with customer-intended solvents.

    Our internal audit system tracks every deviation and incident. Lessons learned from near-misses feed back into revised batch records, process flow updates, and real-time staff training. Teams on the production floor gain exposure to actual use cases—learning which parameters are non-negotiable because they affect the final utility of the product in the lab.

    Long-Term Relationships with Research and Industry

    Staying close to end users keeps us honest and grounded. Clients write or call, describing specific experimental needs or unusual applications. It’s not enough to make a product that technically meets a specification; chemists care about how it mixes, how it reacts, and how much cleanup it leaves behind in their glassware. As manufacturers, we need to hear this and adapt. For instance, a DNA synthesis group pointed out issues with dustiness during automated dispensing, which led our process team to invest in dust-controlled laminar flow workstations and improved sieving steps before final packaging. Small changes, big results for the users.

    Because we know what is involved in setting up a new synthesis or scaling a candidate analog, we maintain flexibility in batch sizes and offer custom packaging. A feedback loop with our commercial and academic partners means that when someone needs a unique intermediate or ultra-high-purity material for preclinical studies, the door is always open. For larger scale projects, making sure each kilo meets the same bar as every gram is a matter of pride as much as policy.

    We keep lines of communication open, inviting onsite visits and audits. Prospective clients have walked through our production suites, inspected records, and met with the same operators who oversee day-to-day synthesis—building trust that spreadsheet statistics can’t offer. Each conversation sharpens our awareness of what matters most in using 6-chloropurine riboside and helps us anticipate trends in nucleoside chemistry.

    Supporting Innovation with Real-World Production Insights

    Every chemical company can reference batch records and analytical data, but the deeper value of manufacturing comes from lived experience. Our technical leads spend time not just in reaction planning, but in the same literature review processes and trouble-shooting routines as our clients. We get calls when something unexpected happens in a downstream reaction—sometimes linked to a rarely-seen impurity, sometimes to an unforeseen side reaction with a solvent. In these cases, sharing expertise or retooling quality analysis isn’t just a formality. It leads to better outcomes for everyone.

    The line between manufacturing and lab support blurs as the industry demands ever-closer alignment between supply chain and user needs. For 6-chloropurine riboside, this means our teams contribute insights from hundreds of kilo-scale runs. By knowing the molecule down to its quirks and edge cases, we help our partners optimize their protocols, avoid purchasing the wrong analog, and get the most value from every order.

    Continuous Improvement: Growing with the Science

    Investing in better analytics and process checks only made sense after learning some lessons the hard way. Early on, batches of 6-chloropurine riboside sometimes failed long-term stability studies—prompting improvements to our drying operations and a shift to more resilient packaging films. Teams discovered that exposure to trace acid vapor during storage subtly altered the melting point and color. We tightened atmospheric controls and began to ship under nitrogen for sensitive clients. The knowledge built up from those changes now benefits every customer.

    We maintain contacts with raw material suppliers, negotiating for higher purities and long-term pricing. Constant verification—incoming, intermediate, and finished—protects more than just our own production lines. It guards the reproducibility of research downstream. Our capacity adapts to demand, shifting floor schedules to respond to academic conference season or trends in oligonucleotide therapeutics. Bulk orders pass through the same rigorous oversight as research-scale lots.

    The Road Ahead: Maintaining Value in Every Lot

    Experience in production counts for more than just efficiency. We see 6-chloropurine riboside growing in demand as therapeutic nucleic acid research picks up speed. Each new project or trial draws on chemistry that has to perform under pressure. Here, being a manufacturer—following every batch from raw material through drum-filling and shipping—means standing behind the product in a way a trader never can. We listen to complaints, track oddities, and push ourselves to deliver a tool you can trust your research with.

    As companies and universities worldwide aim to shorten time from idea to result, our commitment to the details keeps 6-chloropurine riboside not just on the shelf, but at the frontier of new science. We learn as the market evolves, adding capacity where needed and pushing analytical standards forward. Raw experience shapes every improvement. Supporting your science with real-world manufacturing expertise is not just our mission—it’s our daily practice.